Tolero Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference
SALT LAKE CITY, UT - January 4, 2016 - Tolero Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing treatments for serious hematological diseases, today announced that it will present at the 34th Annual J.P. Morgan Healthcare Conference taking place January 11-14, 2016 at the Westin St. Francis Hotel in San Francisco, California. David J. Bearss, Chief Executive Officer, is scheduled to present at 10:30 AM (PST) on Wednesday, January 13, 2016.
Tolero Pharmaceuticals is a clinical stage biopharmaceutical company developing treatments to improve and extend the lives of patients with serious oncological and hematological diseases. Our diverse pipeline targets important biological drivers of blood disorders to treat leukemias and anemia as well as important targets of drug resistance and transcriptional control.
Tolero Pharmaceuticals, Inc.
Click here to open a PDF version